{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:23:23Z","timestamp":1787775803318,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The role of intra-arterial chemotherapy (IAC) for globe salvage treatment of retinoblastoma (RB) has been validated clinically; however, data on its long-term effects remain limited. This study examined the long-term stable salvage rate of IAC in treating RB and assessed its potential adverse effects.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients diagnosed with unilateral advanced intraocular RB who achieved short-term globe salvage and began IAC treatment at our hospital between December 2016 and September 2019 were selected for this study. The collected clinical data included patient demographics, tumor stage, prior treatment history, course of IAC therapy, complications, combination therapy modalities outside of IAC, and long-term follow-up outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Thirty-nine patients were included with a mean age at initial IAC treatment of 1.84 \u00b1 1.18 years. Tumors were located in the right and left eyes of 22 and 17 patients, respectively. Based on the International Intraocular Retinoblastoma Classification (IIRC) grouping, Group D comprised 61.54%, whereas Group E accounted for 38.46% of the cases. The patients received 122 IAC sessions, with a median of three per patient. Follow-up data revealed a 5-year stable globe salvage rate of 87.18% with no treatment-related complications in 15 cases. The primary long-term adverse effects included cataracts, ocular growth arrest, and choroidal retinal atrophy\/optic nerve atrophy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>IAC demonstrated excellent long-term therapeutic efficacy and safety for children with unilateral advanced intraocular RB.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2375_24","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T02:04:20Z","timestamp":1746237860000},"page":"442-446","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Intra-arterial chemotherapy for unilateral advanced intraocular retinoblastoma: A long-term review of a case series"],"prefix":"10.4103","volume":"21","author":[{"given":"Yixiao","family":"Li","sequence":"first","affiliation":[{"name":"Department of Cheeloo College of Medicine, Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglei","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ninth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Vascular Anomalies and Interventional Radiology, Children\u2019s Hospital Affiliated to Shandong University, Jinan, China"},{"name":"Department of Vascular Anomalies and Interventional Radiology, Jinan Children\u2019s Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Vascular Anomalies and Interventional Radiology, Children\u2019s Hospital Affiliated to Shandong University, Jinan, China"},{"name":"Department of Vascular Anomalies and Interventional Radiology, Jinan Children\u2019s Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Vascular Anomalies and Interventional Radiology, Children\u2019s Hospital Affiliated to Shandong University, Jinan, China"},{"name":"Department of Vascular Anomalies and Interventional Radiology, Jinan Children\u2019s Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Vascular Anomalies and Interventional Radiology, Children\u2019s Hospital Affiliated to Shandong University, Jinan, China"},{"name":"Department of Vascular Anomalies and Interventional Radiology, Jinan Children\u2019s Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Vascular Anomalies and Interventional Radiology, Children\u2019s Hospital Affiliated to Shandong University, Jinan, China"},{"name":"Department of Vascular Anomalies and Interventional Radiology, Jinan Children\u2019s Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Vascular Anomalies and Interventional Radiology, Children\u2019s Hospital Affiliated to Shandong University, Jinan, China"},{"name":"Department of Vascular Anomalies and Interventional Radiology, Jinan Children\u2019s Hospital, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2024.04.007","article-title":"Assessment of retinal microvasculature and choroidal vascularity after intra-arterial chemotherapy for retinoblastoma","volume":"266","author":"Yi","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s12519-023-00719-5","article-title":"Clinical analysis of 2790 children with retinoblastoma:A single-center experience in China","volume":"19","author":"Zhang","year":"2023","journal-title":"World J Pediatr"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4103\/0301-4738.190099","article-title":"Adult onset retinoblastoma","volume":"64","author":"Sengupta","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.3390\/cancers15225336","article-title":"Risk of second tumors in retinoblastoma survivors after ionizing radiation:A review","volume":"15","author":"Figueiredo","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/bjo.2010.191130","article-title":"Clinical presentation and group classification of newly diagnosed intraocular retinoblastoma in China","volume":"95","author":"Zhao","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.4103\/jcrt.jcrt_2028_23","article-title":"The role of radiotherapy in multimodal treatment of non-rhabdomyosarcoma soft tissue sarcomas in children:A real life report from a tertiary center","volume":"20","author":"Kahvecioglu","year":"2024","journal-title":"J Cancer Res Ther"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/jnis-2023-020109","article-title":"Advancements in super-selective catheterization and drug selection for intra-arterial chemotherapy for retinoblastoma:A 15-year evolution","volume":"16","author":"Kocharian","year":"2024","journal-title":"J Neurointerv Surg"},{"key":"R8-20250512","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/jnis-2023-020206","article-title":"Absorbable gelatin compressed sponge (Gelfoam) embolization of distal external carotid artery branches in intra-arterial chemotherapy for retinoblastoma","volume":"16","author":"Akkari","year":"2024","journal-title":"J Neurointerv Surg"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S2352-4642(23)00141-4","article-title":"Intravenous versus super-selected intra-arterial chemotherapy in children with advanced unilateral retinoblastoma:An open-label, multicentre, randomised trial","volume":"7","author":"Wen","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2021.09.026","article-title":"Contemporary update of retinoblastoma in China:Three-decade changes in epidemiology, clinical features, treatments, and outcomes","volume":"236","author":"Luo","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/neurintsurg-2022-018957","article-title":"Intra-arterial chemotherapy for retinoblastoma","volume":"15","author":"Carnevale","year":"2023","journal-title":"J Neurointerv Surg"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.3390\/cancers16101899","article-title":"MR Imaging of adverse effects and ocular growth decline after selective intra-arterial chemotherapy for retinoblastoma","volume":"16","author":"de Bloeme","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4143\/crt.2021.1537","article-title":"The efficacy of alternate systemic intravenous chemotherapy and intra-arterial chemotherapy approach for eye globe salvage in retinoblastoma","volume":"55","author":"Han","year":"2023","journal-title":"Cancer Res Treat"},{"key":"R14-20250512","doi-asserted-by":"crossref","first-page":"e12676","DOI":"10.1097\/MD.0000000000012676","article-title":"Intra-arterial chemotherapy for unilateral advanced intraocular retinoblastoma:Results and short-term complications","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.ophtha.2020.09.021","article-title":"Risk factors for acute choroidal ischemia after intra-arterial melphalan for retinoblastoma:The role of the catheterization approach","volume":"128","author":"Stathopoulos","year":"2021","journal-title":"Ophthalmology"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/neuros\/nyaa142","article-title":"The use of alternative routes for the delivery of intra-arterial chemotherapy for retinoblastoma","volume":"87","author":"Sweid","year":"2020","journal-title":"Neurosurgery"},{"issue":"(Suppl 2)","key":"R17-20250512","doi-asserted-by":"crossref","first-page":"S912","DOI":"10.4103\/jcrt.jcrt_1004_22","article-title":"Safety and efficacy of indigenously developed Ruthenium-106 eye plaque for brachytherapy of a spectrum of ocular tumors:A case series","volume":"19","author":"Kumar","year":"2023","journal-title":"J Cancer Res Ther"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1186\/s12885-019-5844-5","article-title":"Intra-arterial chemotherapy as primary or secondary treatment for infants diagnosed with advanced retinoblastoma before 3 months of age","volume":"19","author":"Chen","year":"2019","journal-title":"BMC Cancer"},{"key":"R19-20250512","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/jnis-2023-020170","article-title":"Efficacy of a prolonged stability melphalan formulation for intra-arterial treatment of retinoblastoma","volume":"16","author":"Jubran","year":"2024","journal-title":"J Neurointerv Surg"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"207","DOI":"10.17219\/acem\/166664","article-title":"A meta-analysis of the efficacy of intra-arterial chemotherapy for the management of retinoblastoma patients","volume":"33","author":"Yu","year":"2024","journal-title":"Adv Clin Exp Med"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13816810.2016.1244695","article-title":"Ophthalmic artery chemosurgery for eyes with advanced retinoblastoma","volume":"38","author":"Abramson","year":"2017","journal-title":"Ophthalmic Genet"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jamaophthalmol.2023.4825","article-title":"Incidence and risk factors for neutropenia after intra-arterial chemotherapy for retinoblastoma","volume":"141","author":"Lee","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s12094-021-02610-z","article-title":"The role for intra-arterial chemotherapy for refractory retinoblastoma:A systematic review","volume":"23","author":"Runnels","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"20113","DOI":"10.1038\/s41598-019-56623-4","article-title":"Eye lens radiation exposure in paediatric interventional treatment of retinoblastoma","volume":"9","author":"Obesso","year":"2019","journal-title":"Sci Rep"},{"key":"R25-20250512","first-page":"571","article-title":"Risk factors for cataract in retinoblastoma management","volume":"108","author":"Jia","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"R26-20250512","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1136\/bjophthalmol-2021-319118","article-title":"Risk factors for ophthalmic artery stenosis and occlusion in patients with retinoblastoma treated with intra-arterial chemotherapy","volume":"106","author":"Zhou","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"e30768","DOI":"10.1002\/pbc.30768","article-title":"Intra-arterial chemotherapy for retinoblastoma:Centralization of care is essential","volume":"71","author":"Chantada","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"R28-20250512","doi-asserted-by":"crossref","first-page":"e30718","DOI":"10.1002\/pbc.30718","article-title":"A multi-institutional feasibility study of intra-arterial chemotherapy in children with retinoblastoma. A Children\u203as Oncology Group study (COG ARET12P1)","volume":"71","author":"Chintagumpala","year":"2024","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2375_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:42:32Z","timestamp":1787773352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2375_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2375_24","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"2024-12-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}